Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19

As the global COVID-19 pandemic continues, unabated and clinical trials demonstrate limited effective pharmaceutical interventions, there is a pressing need to accelerate treatment evaluations. Among options for accelerated development is the evaluation of drug combinations in the absence of prior m...

Descripción completa

Detalles Bibliográficos
Autores principales: Rayner, Craig R., Dron, Louis, Park, Jay J. H., Decloedt, Eric H., Cotton, Mark F., Niranjan, Vis, Smith, Patrick F., Dodds, Michael G., Brown, Fran, Reis, Gilmar, Wesche, David, Mills, Edward J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2020
Materias:
Perspective Piece
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543863/
https://www.ncbi.nlm.nih.gov/pubmed/32828137
http://dx.doi.org/10.4269/ajtmh.20-0995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543863/
https://www.ncbi.nlm.nih.gov/pubmed/32828137
http://dx.doi.org/10.4269/ajtmh.20-0995

Ejemplares similares